ALLIANCEBERNSTEIN L.P. - SAGE THERAPEUTICS INC ownership

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 247 filers reported holding SAGE THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.22 and the average weighting 0.2%.

Quarter-by-quarter ownership
ALLIANCEBERNSTEIN L.P. ownership history of SAGE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,257,438
-56.2%
61,1000.0%0.00%0.0%
Q2 2023$2,872,922
+13.2%
61,100
+1.0%
0.00%0.0%
Q1 2023$2,538,580
+10.0%
60,5000.0%0.00%0.0%
Q4 2022$2,307,470
-2.6%
60,5000.0%0.00%0.0%
Q3 2022$2,369,000
-46.5%
60,500
-55.9%
0.00%
-50.0%
Q2 2022$4,430,000
-29.3%
137,162
-27.5%
0.00%0.0%
Q1 2022$6,265,000
+15.0%
189,290
+47.8%
0.00%0.0%
Q4 2021$5,447,000
+35.9%
128,055
+41.6%
0.00%0.0%
Q3 2021$4,008,000
+211.9%
90,446
+300.0%
0.00%
+100.0%
Q2 2021$1,285,000
-98.1%
22,614
-97.4%
0.00%
-96.6%
Q1 2021$66,311,000
+931.4%
885,916
+1092.1%
0.03%
+866.7%
Q4 2020$6,429,000
+310.3%
74,316
+189.9%
0.00%
+200.0%
Q3 2020$1,567,000
+46.4%
25,631
-0.4%
0.00%0.0%
Q2 2020$1,070,000
-33.4%
25,731
-54.0%
0.00%0.0%
Q1 2020$1,607,000
-28.1%
55,941
+80.7%
0.00%0.0%
Q4 2019$2,235,000
-96.2%
30,961
-92.5%
0.00%
-97.2%
Q3 2019$58,167,000
-25.9%
414,618
-3.3%
0.04%
-26.5%
Q2 2019$78,480,000
+10.4%
428,643
-4.1%
0.05%
+6.5%
Q1 2019$71,107,000
+57.4%
447,072
-5.2%
0.05%
+35.3%
Q4 2018$45,168,000
-22.8%
471,529
+13.8%
0.03%
-10.5%
Q3 2018$58,519,000
-18.5%
414,296
-9.7%
0.04%
-24.0%
Q2 2018$71,804,000
-16.5%
458,721
-14.0%
0.05%
-19.4%
Q1 2018$85,954,000
-10.2%
533,642
-8.1%
0.06%
-8.8%
Q4 2017$95,694,000
+154.2%
580,982
-3.8%
0.07%
+142.9%
Q3 2017$37,643,000
-31.1%
604,219
-11.9%
0.03%
-33.3%
Q2 2017$54,598,000
+8.6%
685,562
-3.1%
0.04%
+5.0%
Q1 2017$50,285,000
+3.8%
707,537
-25.5%
0.04%0.0%
Q4 2016$48,464,000
+11.3%
949,163
+0.4%
0.04%
+8.1%
Q3 2016$43,544,000
+37.1%
945,582
-10.3%
0.04%
+37.0%
Q2 2016$31,772,000
+4.6%
1,054,499
+11.3%
0.03%
+3.8%
Q1 2016$30,379,000
-43.2%
947,562
+3.2%
0.03%
-43.5%
Q4 2015$53,513,000
+38.3%
917,882
+0.4%
0.05%
+39.4%
Q3 2015$38,693,000
-22.6%
914,285
+33.5%
0.03%
-19.5%
Q2 2015$50,008,000
+224.3%
685,039
+123.1%
0.04%
+215.4%
Q1 2015$15,420,000
+68.7%
306,997
+23.0%
0.01%
+62.5%
Q4 2014$9,138,000
+13.8%
249,666
-2.0%
0.01%
+14.3%
Q3 2014$8,028,000254,8520.01%
Other shareholders
SAGE THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
RTW INVESTMENTS, LP 5,149,482$105,976,3402.24%
Palo Alto Investors LP 1,005,776$20,698,8701.96%
Boxer Capital, LLC 1,094,000$22,514,5201.20%
Bellevue Group AG 3,513,351$72,304,7641.16%
PDT Partners, LLC 181,625$3,737,8430.47%
EASTERLY INVESTMENT PARTNERS LLC 195,643$4,026,3330.44%
Harvest Investment Services, LLC 30,302$623,6150.40%
Simplify Asset Management Inc. 120,030$2,470,2170.28%
SAMLYN CAPITAL, LLC 739,867$15,226,4630.25%
CAXTON ASSOCIATES LP 68,035$1,400,1600.19%
View complete list of SAGE THERAPEUTICS INC shareholders